Specifically, these assays may allow detection and quantification of GAD65 and GAD65-GADA complexes in prediabetic subjects18 or in patients recently diagnosed with T1D, in order to estimate the loss of beta cells once insulin therapy has been initiated19. This evidence concerns the gene INS and type 1 diabetes mellitus.